Senseonics Holdings, Inc. (SENS)
USD 0.71
(-1.81%)
USD 0.71
(-1.81%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -60.39 Million USD | -142.49% |
| 2022 | 142.11 Million USD | 144.72% |
| 2021 | -317.78 Million USD | -66.36% |
| 2020 | -191.02 Million USD | -51.33% |
| 2019 | -126.23 Million USD | -34.33% |
| 2018 | -93.97 Million USD | -59.0% |
| 2017 | -59.1 Million USD | -34.53% |
| 2016 | -43.93 Million USD | -47.04% |
| 2015 | -29.87 Million USD | -58.2% |
| 2014 | -18.88 Million USD | -0.56% |
| 2013 | -18.77 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 FY | -60.39 Million USD | -142.49% |
| 2023 Q1 | -24.1 Million USD | -18.02% |
| 2023 Q4 | -20.28 Million USD | -7.47% |
| 2023 Q3 | -18.87 Million USD | -9.81% |
| 2023 Q2 | -17.19 Million USD | 28.68% |
| 2022 Q2 | -2.34 Million USD | 97.73% |
| 2022 Q3 | 17.7 Million USD | 856.3% |
| 2022 Q4 | -20.42 Million USD | -215.35% |
| 2022 Q1 | -103.21 Million USD | -145.77% |
| 2022 FY | 142.11 Million USD | 144.72% |
| 2021 Q3 | 188.59 Million USD | 123.37% |
| 2021 Q2 | 84.43 Million USD | 96.75% |
| 2021 Q4 | 225.49 Million USD | 19.57% |
| 2021 Q1 | 42.91 Million USD | 123.8% |
| 2021 FY | -317.78 Million USD | -66.36% |
| 2020 Q1 | -23.42 Million USD | -211.75% |
| 2020 Q4 | -180.3 Million USD | 27.74% |
| 2020 FY | -191.02 Million USD | -51.33% |
| 2020 Q2 | -101.63 Million USD | -333.81% |
| 2020 Q3 | -249.51 Million USD | -145.51% |
| 2019 Q1 | -19.49 Million USD | 37.25% |
| 2019 FY | -126.23 Million USD | -34.33% |
| 2019 Q4 | -7.51 Million USD | 82.36% |
| 2019 Q3 | -42.59 Million USD | -19.61% |
| 2019 Q2 | -35.61 Million USD | -82.63% |
| 2018 Q2 | -7.32 Million USD | 77.04% |
| 2018 Q1 | -31.88 Million USD | 1.89% |
| 2018 Q3 | -29.36 Million USD | -301.11% |
| 2018 Q4 | -31.07 Million USD | -5.82% |
| 2018 FY | -93.97 Million USD | -59.0% |
| 2017 Q3 | -22.27 Million USD | -36.85% |
| 2017 FY | -59.1 Million USD | -34.53% |
| 2017 Q4 | -32.49 Million USD | -45.9% |
| 2017 Q2 | -16.27 Million USD | 6.35% |
| 2017 Q1 | -17.37 Million USD | -40.45% |
| 2016 Q2 | -9.96 Million USD | 8.46% |
| 2016 Q1 | -10.88 Million USD | 8.21% |
| 2016 Q3 | -13.07 Million USD | -31.18% |
| 2016 Q4 | -12.37 Million USD | 5.35% |
| 2016 FY | -43.93 Million USD | -47.04% |
| 2015 FY | -29.87 Million USD | -58.2% |
| 2015 Q1 | -1826.00 USD | 95.62% |
| 2015 Q2 | -8.82 Million USD | -482977.77% |
| 2015 Q3 | -11.21 Million USD | -27.15% |
| 2015 Q4 | -11.86 Million USD | -5.75% |
| 2014 FY | -18.88 Million USD | -0.56% |
| 2014 Q3 | -1659.00 USD | 36.94% |
| 2014 Q4 | -41.64 Thousand USD | -2410.37% |
| 2014 Q1 | -21.65 Thousand USD | 0.0% |
| 2014 Q2 | -2631.00 USD | 87.85% |
| 2013 FY | -18.77 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Perspective Therapeutics, Inc. | -14.67 Million USD | -311.67% |
| Electromed, Inc. | 5.15 Million USD | 1272.66% |
| Catheter Precision, Inc. | -70.57 Million USD | 14.425% |
| Xtant Medical Holdings, Inc. | 660 Thousand USD | 9250.303% |